- Home
- MTNB vs BDRX Comparison
MTNB vs BDRX Comparison
Compare MTNB & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- BDRX
- Stock Information
- Founded
- MTNB 2013
- BDRX 2000
- Country
- MTNB United States
- BDRX United Kingdom
- Employees
- MTNB N/A
- BDRX N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- MTNB Health Care
- BDRX Health Care
- Exchange
- MTNB Nasdaq
- BDRX Nasdaq
- Market Cap
- MTNB 2.6M
- BDRX 2.4M
- IPO Year
- MTNB N/A
- BDRX N/A
- Fundamental
- Price
- MTNB $0.73
- BDRX $4.45
- Analyst Decision
- MTNB Hold
- BDRX Strong Buy
- Analyst Count
- MTNB 1
- BDRX 1
- Target Price
- MTNB N/A
- BDRX $200.00
- AVG Volume (30 Days)
- MTNB 109.7K
- BDRX 24.9K
- Earning Date
- MTNB 11-13-2024
- BDRX 01-17-2025
- Dividend Yield
- MTNB N/A
- BDRX N/A
- EPS Growth
- MTNB N/A
- BDRX N/A
- EPS
- MTNB N/A
- BDRX N/A
- Revenue
- MTNB N/A
- BDRX $104,895.00
- Revenue This Year
- MTNB N/A
- BDRX N/A
- Revenue Next Year
- MTNB N/A
- BDRX N/A
- P/E Ratio
- MTNB N/A
- BDRX N/A
- Revenue Growth
- MTNB N/A
- BDRX N/A
- 52 Week Low
- MTNB $0.48
- BDRX $3.50
- 52 Week High
- MTNB $21.50
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- MTNB 54.46
- BDRX 48.88
- Support Level
- MTNB $0.48
- BDRX $3.83
- Resistance Level
- MTNB $0.60
- BDRX $4.73
- Average True Range (ATR)
- MTNB 0.06
- BDRX 0.33
- MACD
- MTNB 0.06
- BDRX 0.07
- Stochastic Oscillator
- MTNB 83.74
- BDRX 69.89
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.